By Karen Roman SkylineDx said its Merlin CP-GEP molecular test identifies a subset of T1a melanoma patients with sentinel ...

File photo of a Merlin engine being tested. SpaceX said it suffered an anomaly during qualification testing of an engine recently, but that it would not delay upcoming launches. Credit: SpaceX ...

BOSTON, May 22, 2025--(BUSINESS WIRE)--Merlin, the leading developer of assured autonomous flight technology for fixed-wing aircraft, today announced it has received an Experimental Certificate of ...

Testing and validating key system capabilities such as Flight Guidance and Autothrottle significantly progresses Merlin’s supplemental type certificate program and the eventual certification of its ...

SkylineDx said its Merlin CP-GEP molecular test is uniquely recognized by the National Comprehensive Cancer Network (NCCN) for predictive use in select T1 and T2 melanoma patients. The test provides ...

Please provide your email address to receive an email when new articles are posted on . The Merlin test, a clinical-pathologic and gene expression profile, was able to successfully classify 37% of ...

BOSTON & MOJAVE, Calif.--(BUSINESS WIRE)--Merlin, the leading developer of safe, autonomous flight technology for fixed-wing aircraft, today announced it successfully began the flight test campaign of ...

Merlin has obtained an Experimental Certificate of Airworthiness from the Civil Aviation Authority of New Zealand (CAANZ), enabling the company to commence certification flight testing of its ...

BOSTON--(BUSINESS WIRE)--Merlin, the leading developer of assured autonomous flight technology for fixed-wing aircraft, today announced it’s rapidly progressing the flight test campaign of its ...